Literature DB >> 17236658

Resected well-differentiated fetal pulmonary adenocarcinoma and summary of 25 cases reported in Japan.

Shuichi Sato1, Teruaki Koike, Yasushi Yamato, Katsuo Yoshiya, Keiichi Honma, Hiroko Tsukada.   

Abstract

We report a case of well-differentiated fetal adenocarcinoma (WDFA), which is a variant of pulmonary blastoma. A 36-year-old man was found to have a tumor shadow in the right middle field of a chest radiograph as part of a mass screening examination, and chest computed tomography (CT) showed a 4.5-cm pulmonary mass in the right lower lobe. A diagnosis of adenocarcinoma of the lung was made based on a CT-guided needle biopsy, and right middle and lower lobectomy and lymph node dissection were performed. The postoperative pathological diagnosis was well-differentiated fetal adenocarcinoma. WDFA has a better prognosis than conventional pulmonary blastoma (biphasic pulmonary blastoma). We summarize the cases of WDFA reported in Japan and review the literature.

Entities:  

Mesh:

Year:  2006        PMID: 17236658     DOI: 10.1007/s11748-006-0048-8

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  8 in total

1.  Embryoma of lungs.

Authors:  W G BARNARD
Journal:  Thorax       Date:  1952-12       Impact factor: 9.139

Review 2.  Pulmonary blastoma: a review with special emphasis on prognosis and treatment.

Authors:  H Larsen; J B Sørensen
Journal:  Cancer Treat Rev       Date:  1996-05       Impact factor: 12.111

3.  Pulmonary blastoma.

Authors:  D Francis; M Jacobsen
Journal:  Curr Top Pathol       Date:  1983

Review 4.  Pleuropulmonary blastoma. The so-called pulmonary blastoma of childhood.

Authors:  J C Manivel; J R Priest; J Watterson; M Steiner; W G Woods; M R Wick; L P Dehner
Journal:  Cancer       Date:  1988-10-15       Impact factor: 6.860

5.  Pulmonary blastoma: medium-term results from a regional center.

Authors:  Afzal Zaidi; Vipin Zamvar; Fergus Macbeth; Allen R Gibbs; Nihal Kulatilake; Eric G Butchart
Journal:  Ann Thorac Surg       Date:  2002-05       Impact factor: 4.330

6.  Pulmonary blastomas.

Authors:  M N Koss; L Hochholzer; T O'Leary
Journal:  Cancer       Date:  1991-05-01       Impact factor: 6.860

7.  Beta-catenin mutations in pulmonary blastomas: association with morule formation.

Authors:  Shigeki Sekine; Tatsuhiro Shibata; Yoshihiro Matsuno; Arafumi Maeshima; Genichiro Ishii; Michiie Sakamoto; Setsuo Hirohashi
Journal:  J Pathol       Date:  2003-06       Impact factor: 7.996

8.  Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.

Authors:  Yukio Nakatani; Katsuhiko Masudo; Yohei Miyagi; Yoshiaki Inayama; Naomi Kawano; Yukichi Tanaka; Keisuke Kato; Takaaki Ito; Hitoshi Kitamura; Yoji Nagashima; Shoji Yamanaka; Nobuo Nakamura; Jinyu Sano; Nobuo Ogawa; Naoki Ishiwa; Kenji Notohara; Milan Resl; Eugene J Mark
Journal:  Mod Pathol       Date:  2002-06       Impact factor: 7.842

  8 in total
  10 in total

1.  Differences between low and high grade fetal adenocarcinoma of the lung: a clinicopathological and molecular study.

Authors:  Jing Zhang; Jian Sun; Xiao-Long Liang; Jun-Liang Lu; Yu-Feng Luo; Zhi-Yong Liang
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Well-differentiated fetal adenocarcinoma of the lung: clinicopathologic features of 45 cases in China.

Authors:  Tong-Mei Zhang; Bao-Hua Lu; Yi-Ran Cai; Yuan Gao; Hong-Mei Zhang; Qun-Hui Wang; Ai-Min Hu; Bao-Lan Li
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  Pulmonary well-differentiated fetal adenocarcinoma with platelet-derived growth factor receptor (PDGFR)α expression.

Authors:  Can-Qiao Luo; Sai-Ching J Yeung; Zhen-Guo Liu; Jun Meng; Fo-tian Zhong; Chao Cheng
Journal:  Cancer Biol Ther       Date:  2012-09-17       Impact factor: 4.742

4.  Well differentiated fetal adenocarcinoma of the lung in a 38-year-old woman: dynamic computed tomography findings.

Authors:  Takana Yamakawa; Atsushi Nambu; Satoshi Kato; Masashi Kawamoto; Shozo Fujino; Masato Watanabe; Masao Tago
Journal:  Jpn J Radiol       Date:  2012-10-31       Impact factor: 2.374

5.  A case of locally advanced well-differentiated fetal adenocarcinoma of the lung treated with concurrent chemoradiation therapy.

Authors:  Chanhee Kyung; Sang Young Kim; Beom Jin Lim; Jung-Joon Cha; Hyung Jung Kim; Chul Min Ahn; Heejin Park; Eun Na Cho; Yoon Soo Chang
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-05-31

Review 6.  [Well-differentiated fetal adenocarcinoma of lung: a case report with 14 cases literature review].

Authors:  Tongmei Zhang; Na Qin; Baolan Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-08

Review 7.  Comprehensive review of fetal adenocarcinoma of the lung.

Authors:  Luisa María Ricaurte; Oscar Arrieta; Zyanya Lucia Zatarain-Barrón; Andrés F Cardona
Journal:  Lung Cancer (Auckl)       Date:  2018-08-23

8.  High-grade fetal adenocarcinoma of the lung with abnormal expression of alpha-fetoprotein in a female patient: Case report.

Authors:  Lu Xiao-Feng; Zhou Guo-Qi; Hu Wei; Li Jing-Hong; Ding Chao-Xia; Cai Xiao-Yan; Xun Yang
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

9.  Comprehensive molecular analysis of genomic profiles and PD-L1 expression in lung adenocarcinoma with a high-grade fetal adenocarcinoma component.

Authors:  Masaki Suzuki; Rika Kasajima; Tomoyuki Yokose; Hiroyuki Ito; Eigo Shimizu; Seira Hatakeyama; Kazuaki Yokoyama; Rui Yamaguchi; Yoichi Furukawa; Satoru Miyano; Seiya Imoto; Emi Yoshioka; Kota Washimi; Yoichiro Okubo; Kae Kawachi; Shinya Sato; Yohei Miyagi
Journal:  Transl Lung Cancer Res       Date:  2021-03

10.  Neoadjuvant chemotherapy in well-differentiated fetal adenocarcinoma: a case report.

Authors:  Sihame Lkhoyaali; Saber Boutayeb; Nabil Ismaili; Meriem Aitelhaj; Fahd Ouchen; Abdellatif Benosman; Hassan Errihani
Journal:  BMC Res Notes       Date:  2014-05-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.